Oncotarget

Research Papers:

Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma

Iris Chiara Salaroglio _, Ivana Campia, Joanna Kopecka, Elena Gazzano, Sara Orecchia, Dario Ghigo and Chiara Riganti

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2015; 6:1128-1142. https://doi.org/10.18632/oncotarget.2731

Metrics: PDF 1932 views  |   HTML 1852 views  |   ?  


Abstract

Iris Chiara Salaroglio1,*, Ivana Campia1,*, Joanna Kopecka1, Elena Gazzano1, Sara Orecchia2, Dario Ghigo1, Chiara Riganti1

1Department of Oncology, University of Torino, Italy

2S.C. Anatomia Patologica, Azienda Ospedaliera S.S. Antonio e Biagio, Alessandria, Italy

*These authors have contributed equally to this work

Correspondence to:

Dario Ghigo, e-mail: dario.ghigo@unito.it

Keywords: malignant mesothelioma, chemoresistance, immunosuppression, indoleamine 1,2 dioxygenase, zoledronic acid

Received: August 28, 2014     Accepted: November 11, 2014     Published: December 31, 2014

ABSTRACT

The human malignant mesothelioma (HMM) is characterized by a chemoresistant and immunosuppressive phenotype. An effective strategy to restore chemosensitivity and immune reactivity against HMM is lacking. We investigated whether the use of zoledronic acid is an effective chemo-immunosensitizing strategy.

We compared primary HMM samples with non-transformed mesothelial cells.

HMM cells had higher rate of cholesterol and isoprenoid synthesis, constitutive activation of Ras/extracellular signal-regulated kinase1/2 (ERK1/2)/hypoxia inducible factor-1α (HIF-1α) pathway and up-regulation of the drug efflux transporter P-glycoprotein (Pgp). By decreasing the isoprenoid supply, zoledronic acid down-regulated the Ras/ERK1/2/HIF-1α/Pgp axis and chemosensitized the HMM cells to Pgp substrates. The HMM cells also produced higher amounts of kynurenine, decreased the proliferation of T-lymphocytes and expanded the number of T-regulatory (Treg) cells. Kynurenine synthesis was due to the transcription of the indoleamine 1,2 dioxygenase (IDO) enzyme, consequent to the activation of the signal transducer and activator of transcription-3 (STAT3). By reducing the activity of the Ras/ERK1/2/STAT3/IDO axis, zoledronic acid lowered the kyurenine synthesis and the expansion of Treg cells, and increased the proliferation of T-lymphocytes.

Thanks to its ability to decrease Ras/ERK1/2 activity, which is responsible for both Pgp-mediated chemoresistance and IDO-mediated immunosuppression, zoledronic acid is an effective chemo-immunosensitizing agent in HMM cells.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 2731